Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
暂无分享,去创建一个
C. Pasquier | J. Izopet | L. Bujan | K. Sauné | C. Souyris | M. Daudin | N. Moinard | M. Lavit
[1] C. Rouzioux,et al. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. , 2008, The Journal of antimicrobial chemotherapy.
[2] P. Roques,et al. Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the Disease , 2008, PloS one.
[3] S. Kalichman,et al. Human Immunodeficiency Virus Viral Load in Blood Plasma and Semen: Review and Implications of Empirical Findings , 2008, Sexually transmitted diseases.
[4] J. Ray,et al. Quantification of antiretroviral drugs for HIV‐1 in the male genital tract: current data, limitations and implications for laboratory analysis , 2007, The Journal of pharmacy and pharmacology.
[5] V. Soriano,et al. Is natural conception a valid option for HIV-serodiscordant couples? , 2007, Human reproduction.
[6] Christophe Pasquier,et al. Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies , 2007, Journal of Clinical Microbiology.
[7] A. Wensing,et al. No Virological Failure in Semen During Properly Suppressive Antiretroviral Therapy Despite Subtherapeutic Local Drug Concentrations , 2006, HIV clinical trials.
[8] A. Collier,et al. Lower Genitourinary Tract Sources of Seminal HIV , 2006, Journal of acquired immune deficiency syndromes.
[9] J. Mellors,et al. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. , 2004, AIDS research and human retroviruses.
[10] C. Katlama,et al. Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men , 2004, AIDS.
[11] P. Cane,et al. Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen. , 2004, The Journal of antimicrobial chemotherapy.
[12] A. Antinori,et al. Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay. , 2004, In vivo.
[13] A. Berrebi,et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes , 2004, AIDS.
[14] Roland Tubiana,et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men , 2004, AIDS.
[15] C. Rouzioux,et al. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). , 2002, AIDS.
[16] C. Solas,et al. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations , 2002, HIV clinical trials.
[17] D. Pillay,et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis , 2002, AIDS.
[18] A. Kiessling,et al. Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy. , 2000, Urology.
[19] Hui Zhang,et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. , 1998, The New England journal of medicine.